% | $
Quotes you view appear here for quick access.

SciClone Pharmaceuticals, Inc. Message Board

  • nawchi nawchi Aug 4, 2005 9:56 AM Flag

    Zadaxin (for new investors)

    Zadaxin� (thymosin alpha 1)

    A synthetically produced immunomodulator that stimulates the immune system's disease-fighting properties. Potential indications include the treatment of patients with hepatitis B and C; HIV/AIDS; cancer, including liver cancer, melanoma, non�small cell lung cancer, and colorectal cancer. Orphan drug designation for the treatment of hepatocellular carcinoma granted in March 2000. Approved in several overseas markets; investigational in the U.S. where clinical trials are underway related to the use of Zadaxin (1) in combination with interferon as treatment for hepatitis C; (2) as monotherapy or in combination with certain antiviral drugs as treatment for hepatitis B; (3) in combination with chemotherapy for the treatment of cancer; (4) in combination with radiofrequency ablation (RFA) and in combination with transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma. Mfg: SciClone Pharmaceuticals, Inc. Source: PR Newswire - 11/12/96, 03/22/00, 01/08/01.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
12.78-0.31(-2.37%)Jun 27 4:00 PMEDT